77173-3

LOINC 2.82

Hepatocyte growth factor receptor Ag [Presence] in Tissue by Immune stain

HGFR Ag Tiss Ql ImStn

Definition

  • The stain is interpreted as positive if 50% or more of the tumor cells show moderate to strong (2+, 3+) membranous staining, indicating MET amplification. MET amplification (positive) has been seen in approximately 22% of non-small-cell lung cases with acquired resistance to anti-EGFR inhibitors. Recent Phase II clinical trails (OAM4558g) results were released at ASCO in 2011 showed that patients who were c-MET positive (2+ or 3+) lived twice as long without disease progression (PFS) when they received MetMAb therapy in combination with erlotinib versus receiving erlotinib alone.

Component

  • Hepatocyte growth factor receptor Ag

Specimen / system

  • Tiss

Class

  • PATH

Property

  • PrThr

Scale

  • Ord

Method

  • Immune stain

Related names

  • Antigen; Antigens; c-Met; Fac; Fact; Hepatopoietin A; HGF; HGFR; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; mesenchymal-epithelial transition; MET; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Scatter factor; Scatter Factor Receptor; Screen; SFR; St; Stains; Stn; Tissue; Tissue, unspecified; Transmembrane tyrosine kinase receptor; Tyrosine-protein kinase Met

Index terms

  • Antigen
  • Antigens
  • c-Met
  • Fac
  • Fact
  • Hepatopoietin A
  • HGF
  • HGFR
  • IHC
  • Imm
  • Immunohistochemical stain
  • Immunostain
  • ImStn
  • Imun
  • Imune
  • mesenchymal-epithelial transition
  • MET
  • Ordinal
  • PATHOLOGY
  • Point in time
  • PR
  • QL
  • Qual
  • Qualitative
  • Random
  • Rec
  • Recept
  • Receptors
  • Recp
  • Recptr
  • Scatter factor
  • Scatter Factor Receptor
  • Screen
  • SFR
  • St
  • Stains
  • Stn
  • Tissue
  • Tissue, unspecified
  • Transmembrane tyrosine kinase receptor

1 further terms